Abstract:The canonical Wnt signaling pathway is involved in a variety of biological processes like cell proliferation, cell polarity, and cell fate determination. This pathway has been extensively investigated as its deregulation is linked to different diseases, including various types of cancer, skeletal defects, birth defect disorders (including neural tube defects), metabolic diseases, neurodegenerative disorders and several fibrotic diseases like desmoid tumors. In the "on state", beta-catenin, the key effector of Wnt signaling, enters the nucleus where it binds to the members of the TCF-LEF family of transcription factors and exerts its effect on gene transcription. Disease development can be caused by direct or indirect alterations of the Wnt/β-catenin signaling. In the first case germline or somatic mutations of the Wnt components are associated to several diseases such as the familial adenomatous polyposis (FAP) - caused by germline mutations of the tumor suppressor adenomatous polyposis coli gene (APC) - and the desmoid-like fibromatosis, a sporadic tumor associated with somatic mutations of the β-catenin gene (CTNNB1). In the second case, epigenetic modifications and microenvironmental factors have been demonstrated to play a key role in Wnt pathway activation. The natural autocrine Wnt signaling acts through agonists and antagonists competing for the Wnt receptors. Anomalies in this regulation, whichever is their etiology, are an important part in the pathogenesis of Wnt pathway linked diseases. An example is promoter hypermethylation of Wnt antagonists, such as SFRPs, that causes gene silencing preventing their function and consequently leading to the activation of the Wnt pathway. Microenvironmental factors, such as the extracellular matrix, growth factors and inflammatory mediators, represent another type of indirect mechanism that influence Wnt pathway activation. A favorable microenvironment can lead to aberrant fibroblasts activation and accumulation of ECM proteins with subsequent tissue fibrosis that can evolve in fibrotic disease or tumor. Since the development and progression of several diseases is the outcome of the Wnt pathway cross-talk with other signaling pathways and inflammatory factors, it is important to consider not only direct inhibitors of the Wnt signaling pathway but also inhibitors of microenvironmental factors as promising therapeutic approaches for several tumors of fibrotic origin.

Role of developmental pathways in disease

Major Physiological Signaling Pathways in the Regulation of Cell Proliferation and Survival

Role and Mechanisms of the NF-ĸB Signaling Pathway in Various Developmental Processes

Developmental pathways: Sonic hedgehog-Patched-GLI

THE WNT SIGNALING PATHWAY IN DEVELOPMENT AND DISEASE

Wnt signaling in development and tissue homeostasis

Cellular senescence and developmental defects

Transcription Factors That Govern Development and Disease: An Achilles Heel in Cancer

Wnt/β-Catenin Signaling and Disease

p65 signaling dynamics drive the developmental progression of hematopoietic stem and progenitor cells through cell cycle regulation

Merlin regulates signaling events at the nexus of development and cancer

The Wnt/β-catenin pathway in human fibrotic-like diseases and its eligibility as a therapeutic target

Signalling dynamics in embryonic development

The universal role of adaptive transcription in health and disease

Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities

JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens

Signaling in Fibrosis: TGF-β, WNT, and YAP/TAZ Converge

Cell Cycle Regulation and Cytoskeletal Remodelling Are Critical Processes in the Nutritional Programming of Embryonic Development

Wnt signaling pathway in development and cancer.

MAP/ERK Signaling in Developing Cognitive and Emotional Function and Its Effect on Pathological and Neurodegenerative Processes